The authors found that malignant and benign T cells from leukemic CTCL patients expressed lower levels of IFNγ and higher levels of IL-4 and IL-13 than T cells from healthy controls. Here, IL4 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.